Search

everythinglearnresearchcommunity

for

Search:↓

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Hormones and genes affect hair growth and male baldness.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Finasteride may cause kidney damage.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Androgens can both increase body hair and cause scalp hair loss.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Male hormones can cause hair loss, but treatments like Minoxidil and Finasteride can help, and targeting TGF-B1 could be a future solution.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Exosomes from stem cells help hair regrowth by activating a specific signaling pathway.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.